The clinical trials

At Bossology™, we take our responsibility to our customers seriously. Every product we create is backed by peer-reviewed scientific research, GMP compliant according to the FDA, and third party tested for potency and purity.

We believe in transparency and want to empower our customers to make informed decisions about their wellbeing. That's why we encourage our customers to remain informed, do their research and take responsibility for their own education. By arming yourself with knowledge, you can make the best choices for your body.

So that you can do your own research, we highly recommend reading the following journals.

With great powder, comes great responsibility

Myo & D-Chiro Inositol Studies


This study, conducted on normal weight women with PCOS, found that myo-inositol significantly improved insulin sensitivity and hormonal balance, suggesting a potential therapeutic approach for managing PCOS symptoms.


This study suggested that targeted peri-conceptional D-chiro inositol supplementation may benefit patients with endometriosis-related infertility, indicating the need for further investigation into this potential treatment.


Levine et al.'s (1995) double-blind, controlled trial found that inositol treatment effectively improved depressive symptoms, supporting its potential use in managing depression.


This study reported that D-chiro-inositol induced ovulation in two cases of non-PCOS, non-insulin-resistant young women, likely by modulating aromatase expression, suggesting a potential therapeutic application for this compound in similar cases.


This meta-analysis of randomized trials found that inositol treatment effectively improved anovulation in women with polycystic ovary syndrome (PCOS), supporting its potential therapeutic role in PCOS management.


The systematic review and meta-analysis revealed that inositol supplementation could significantly reduce body mass index, suggesting its potential effectiveness in weight management interventions.


This randomized study demonstrated that myo-inositol administration in PCOS patients resulted in improved endocrine and clinical outcomes, indicating its potential as a treatment for PCOS.


In this double-blind trial, myo-inositol supplementation was found to improve oocyte quality in PCOS patients, suggesting a potential benefit for fertility treatments.


This review of controlled trials in psychiatry showed that inositol had promising effects on various psychiatric conditions, indicating its potential as a treatment option in mental health care.


This case-control study demonstrated that inositol administration in PCOS patients resulted in similar improvements in hormonal and metabolic profiles compared to metformin, providing valuable insights for optimizing treatment strategies.


This study investigated the use of insulin-sensitizing agents alone or in combination with r-FSH for ovulation induction in PCOS women, contributing to the understanding of effective treatment options.


This randomized, double-blind, placebo-controlled trial reported that both myo-inositol significantly improved mental health parameters and reduced oxidative stress biomarkers in women with PCOS, supporting their potential use in treating related symptoms.

Chasteberry Studies